Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
7% Hypertonic Saline Before ELTGOL in Bronchiectasis
2024-511677-29-01Phase 4Authorised
- Sponsor
- Hospital Universitari de Girona Dr. Josep Trueta
- Start
- Nov 2024
- Countries
- 1
01
Overview
Phase 4, randomised trial of sodium chloride in bronchiectasis (2 arms), sponsored by Hospital Universitari de Girona Dr. Josep Trueta. Primary endpoint: Change in sputum weight during intervention. Planned start Nov 2024; status: authorised.
02
Drugs
sodium chloride
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on 2024-511677-29-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511677-29-01.